Off Topic Things that aren't worth a new thread ...
- Thread starter Smug in Boots
- Start date
-
Please bear with us on the new site integration and fixing any known bugs over the coming days. If you can not log in please try resetting your password and check your spam box. If you have tried these steps and are still struggling email [email protected] with your username/registered email address
-
Along with "mobile Leper colony" I hope.I'm just off to have it copyrighted
I haven't forgot that one.
Last edited:
You must log in or register to see images
Long story cut shortHoned, Vince . . . . honed
What have you done to your foot
Had my big toe nails taken off 5th April
Got an infection spread to the toe bone
On double antibiotics for 6 weeks since 8th June so no sea no sand no sun no pool
And very little alcohol it takes a long time to heal
Keane & Dalglish 
You must log in or register to see media
That photo of you looked tanned as **** standing next to a pool makes me wonder how seriously you're taking those instructions
Just missing a pint in your hand
Just got back from a week in Robin hoods bay and some of the ESSO garages are still at £1,74 a ltr , Sainsbury’s £ I, 34 just along the road.
Nearly bloody killed usHow did you manage that steep hill at your age mate
left the car at the church for the full week.
You must log in or register to see images
That was Scarborough mate
Yes I'm sure raw sewage knows it should stay within it's allocated zone and ignore the tides
It’s a good turd that travels 17 mls in a North East SeaYes I'm sure raw sewage knows it should stay within it's allocated zone and ignore the tides
The danger of drugs . . . .
https://www.bbc.co.uk/news/world-australia-66072427
Australia legalises psychedelics for mental health
Image caption,
Magic mushrooms have hallucinogenic effects due to the drug psilocybin
By Tiffany Wertheimer
BBC News
Australia has become the first country in the world to legalise the use of psychedelics to treat some mental health conditions.
Approved psychiatrists can now prescribe MDMA to those suffering post-traumatic stress disorder and magic mushrooms for some types of depression.
The controversial move has been hailed as a game-changer by many scientists and mental health experts, but others say that the move has been too hasty and should not be over-hyped.
Experts say that there is still the risk of "a bad trip", which is when the user has an unpleasant experience while under the influence of drugs.
The therapy comes at a high cost, too, with Australian media reporting that one course could cost tens of thousands of dollars.
MDMA - also known as the party drug, ecstasy - is a synthetic drug that acts as a hallucinogen. It increases the user's energy levels & sensory experiences, and distorts their sense of time.
Magic mushrooms, which grow naturally, also have hallucinogenic effects due to the active compound, psilocybin.
While Australia is the first country in the world to regulate the drugs as medications, clinical trials are also underway in the US, Canada and Israel.
Under the new regulations which became official in Australia today (1st July) approved psychiatrists can prescribe MDMA for post-traumatic stress disorder (PTSD), and psilocybin for depression that has resisted other treatments.
Describing the move as a "game-changer", he told AFP news agency that, in the case of MDMA for example, the patient would likely have three treatments over five to eight weeks. Each treatment would last about eight hours, with the therapist staying with the patient during that time.
Patients should not expect a miracle cure, however.
"I have read about stories where people have had what you call bad trips, or actually they've re-experienced their trauma, so we've got to take great caution," Dr Musker said.
Professor Susan Rossell, a cognitive neuropsychologist at Melbourne's Swinburne University, said that while psychedelics certainly had the potential for therapeutic use, the move had come about too quickly.
"When you look at interventions, for any other kind of disease, whether it's cardiovascular disease or cancer, you can not get a drug to market as quickly as this has been done," she told AFP.
Prof. Rossell, who is leading Australia's biggest trial about the effects of psilocybin on depression, said that more research was needed to determine the long-term outcomes of the therapy.
Australia's Therapeutic Goods Administration (TGA) shocked many in the medical and science world in February when it reclassified MDMA and psilocybin so that they could be used for therapeutic purposes.
It declared the drugs "relatively safe" when used in a "medically-controlled environment" for patients "with serious mental health conditions."
Otherwise, both MDMA and psilocybin are illegal in Australia.
The TGA acknowledges that there are unknowns and inconclusive evidence, but says "there are promising signs" that controlled therapeutic use of the drugs may improve mental health for some people, and that the "benefits for some patients will outweigh the risks."
The regulator says that there are currently no approved products that contain MDMA or psilocybin, but the reclassification means that psychiatrists will be able to access and legally supply certain medicines that contain them, even if they have not been evaluated for safety or effectiveness.
This sounds dangerous to me, but if it works it could be beneficial for some, if affordable.
https://www.bbc.co.uk/news/world-australia-66072427
Australia legalises psychedelics for mental health
- Published
10 hours ago
You must log in or register to see images
IMAGE SOURCE,GETTY IMAGESImage caption,
Magic mushrooms have hallucinogenic effects due to the drug psilocybin
By Tiffany Wertheimer
BBC News
Australia has become the first country in the world to legalise the use of psychedelics to treat some mental health conditions.
Approved psychiatrists can now prescribe MDMA to those suffering post-traumatic stress disorder and magic mushrooms for some types of depression.
The controversial move has been hailed as a game-changer by many scientists and mental health experts, but others say that the move has been too hasty and should not be over-hyped.
Experts say that there is still the risk of "a bad trip", which is when the user has an unpleasant experience while under the influence of drugs.
The therapy comes at a high cost, too, with Australian media reporting that one course could cost tens of thousands of dollars.
MDMA - also known as the party drug, ecstasy - is a synthetic drug that acts as a hallucinogen. It increases the user's energy levels & sensory experiences, and distorts their sense of time.
Magic mushrooms, which grow naturally, also have hallucinogenic effects due to the active compound, psilocybin.
While Australia is the first country in the world to regulate the drugs as medications, clinical trials are also underway in the US, Canada and Israel.
Under the new regulations which became official in Australia today (1st July) approved psychiatrists can prescribe MDMA for post-traumatic stress disorder (PTSD), and psilocybin for depression that has resisted other treatments.
- Australia begins world-first MDMA therapy for PTSD
- MDMA could help trauma survivors face memories
- Psychedelic therapy could 'reset' depressed brain
Describing the move as a "game-changer", he told AFP news agency that, in the case of MDMA for example, the patient would likely have three treatments over five to eight weeks. Each treatment would last about eight hours, with the therapist staying with the patient during that time.
Patients should not expect a miracle cure, however.
"I have read about stories where people have had what you call bad trips, or actually they've re-experienced their trauma, so we've got to take great caution," Dr Musker said.
Professor Susan Rossell, a cognitive neuropsychologist at Melbourne's Swinburne University, said that while psychedelics certainly had the potential for therapeutic use, the move had come about too quickly.
"When you look at interventions, for any other kind of disease, whether it's cardiovascular disease or cancer, you can not get a drug to market as quickly as this has been done," she told AFP.
Prof. Rossell, who is leading Australia's biggest trial about the effects of psilocybin on depression, said that more research was needed to determine the long-term outcomes of the therapy.
Australia's Therapeutic Goods Administration (TGA) shocked many in the medical and science world in February when it reclassified MDMA and psilocybin so that they could be used for therapeutic purposes.
It declared the drugs "relatively safe" when used in a "medically-controlled environment" for patients "with serious mental health conditions."
Otherwise, both MDMA and psilocybin are illegal in Australia.
The TGA acknowledges that there are unknowns and inconclusive evidence, but says "there are promising signs" that controlled therapeutic use of the drugs may improve mental health for some people, and that the "benefits for some patients will outweigh the risks."
The regulator says that there are currently no approved products that contain MDMA or psilocybin, but the reclassification means that psychiatrists will be able to access and legally supply certain medicines that contain them, even if they have not been evaluated for safety or effectiveness.
This sounds dangerous to me, but if it works it could be beneficial for some, if affordable.